"Pharmaceutical Corporate Compliance" from FDANews.
The company said the new title answers "critical compliance questions drug companies are asking" and provides guidelines for developing, monitoring and managing effective compliance programs. Targeted to corporate executives, attorneys, compliance experts and consultants, the newsletter covers legislative and regulatory news and developments, compliance tips and strateties, and ethical issues.
Editorial includes stories on such topics as: the FTC's pledge to increase drug company antitrust investigations; the new CME standards; state AG enforcement initiatives; the Sarbanes-Oxley Act; HIPAA privacy issues; and Qui Tam actions.
Related FDANews title include Drug Industry Daily, Washington Drug Letter, Part 11 Compliance Report, Generic Line and Devices & Diagnostics Letter.
|Printer friendly Cite/link Email Feedback|
|Date:||Dec 31, 2003|
|Previous Article:||New info service, "Communications Regulation," from Pike & Fischer.|
|Next Article:||W.S. Hein & Co. expands databases W/purchase of law journal content.|